GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Teva Pharmaceutical Industries Ltd (WBO:TEVA) » Definitions » Shiller PE Ratio

Teva Pharmaceutical Industries (WBO:TEVA) Shiller PE Ratio : (As of May. 17, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Teva Pharmaceutical Industries Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Teva Pharmaceutical Industries Shiller PE Ratio Historical Data

The historical data trend for Teva Pharmaceutical Industries's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Teva Pharmaceutical Industries Shiller PE Ratio Chart

Teva Pharmaceutical Industries Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Teva Pharmaceutical Industries Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Teva Pharmaceutical Industries's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Teva Pharmaceutical Industries's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Teva Pharmaceutical Industries's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Teva Pharmaceutical Industries's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Teva Pharmaceutical Industries's Shiller PE Ratio falls into.



Teva Pharmaceutical Industries Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Teva Pharmaceutical Industries's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Teva Pharmaceutical Industries's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.11/131.7762*131.7762
=-0.110

Current CPI (Mar. 2024) = 131.7762.

Teva Pharmaceutical Industries Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 0.640 100.560 0.839
201409 0.792 100.428 1.039
201412 0.649 99.070 0.863
201503 0.480 99.621 0.635
201506 0.561 100.684 0.734
201509 0.107 100.392 0.140
201512 0.505 99.792 0.667
201603 0.557 100.470 0.731
201606 0.178 101.688 0.231
201609 0.312 101.861 0.404
201612 -1.052 101.863 -1.361
201703 0.533 102.862 0.683
201706 -5.287 103.349 -6.741
201709 0.436 104.136 0.552
201712 -9.641 104.011 -12.215
201803 0.835 105.290 1.045
201806 -0.205 106.317 -0.254
201809 -0.231 106.507 -0.286
201812 -2.505 105.998 -3.114
201903 -0.089 107.251 -0.109
201906 -0.558 108.070 -0.680
201909 -0.263 108.329 -0.320
201912 0.090 108.420 0.109
202003 0.054 108.902 0.065
202006 0.115 108.767 0.139
202009 -3.371 109.815 -4.045
202012 0.115 109.897 0.138
202103 0.059 111.754 0.070
202106 0.158 114.631 0.182
202109 0.221 115.734 0.252
202112 -0.124 117.630 -0.139
202203 -0.781 121.301 -0.848
202206 -0.199 125.017 -0.210
202209 0.051 125.227 0.054
202212 -1.038 125.222 -1.092
202303 -0.187 127.348 -0.194
202306 -0.711 128.729 -0.728
202309 0.066 129.860 0.067
202312 0.376 129.419 0.383
202403 -0.110 131.776 -0.110

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Teva Pharmaceutical Industries  (WBO:TEVA) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Teva Pharmaceutical Industries Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Teva Pharmaceutical Industries's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Teva Pharmaceutical Industries (WBO:TEVA) Business Description

Address
124 Dvora HaNevi’a Street, Tel Aviv, ISR, 6944020
Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the U.S. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: central nervous system with Copaxone, Ajovy and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a U.S.-based generic and specialty drug distributor.